Parkinsons Disease

Papers
(The TQCC of Parkinsons Disease is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Social Symptoms of Parkinson’s Disease24
Freezing of Gait in Parkinson’s Disease: Risk Factors, Their Interactions, and Associated Nonmotor Symptoms16
Association of p53 with Neurodegeneration in Parkinson’s Disease15
Dance Is an Accessible Physical Activity for People with Parkinson’s Disease14
Action Imagery and Observation in Neurorehabilitation for Parkinson’s Disease (ACTION-PD): Development of a User-Informed Home Training Intervention to Improve Functional Hand Movements13
Self-Management Components as Experienced by People with Parkinson’s Disease and Their Carers: A Systematic Review and Synthesis of the Qualitative Literature13
Transcranial Sonography of the Substantia Nigra for the Differential Diagnosis of Parkinson’s Disease and Other Movement Disorders: A Meta-Analysis11
Lee Silverman Voice Treatment to Improve Speech in Parkinson’s Disease: A Systemic Review and Meta-Analysis11
Focus on Depression in Parkinson’s Disease: A Delphi Consensus of Experts in Psychiatry, Neurology, and Geriatrics10
Enhancement of Executive Functions but Not Memory by Multidomain Group Cognitive Training in Patients with Parkinson’s Disease and Mild Cognitive Impairment: A Multicenter Randomized Controlled Trial10
The Origin of Abnormal Beta Oscillations in the Parkinsonian Corticobasal Ganglia Circuits10
Abnormal Gray Matter Volume and Functional Connectivity in Parkinson’s Disease with Rapid Eye Movement Sleep Behavior Disorder10
Movement Disorders Associated with COVID-199
Perspectives on Care for Late-Stage Parkinson’s Disease9
Diagnostic Test to Identify Parkinson’s Disease from the Blood Sera of Chinese Population: A Cross-Sectional Study7
Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines7
Social Cognition in Patients with Early-Onset Parkinson’s Disease7
Characterizing Advanced Parkinson’s Disease: Romanian Subanalysis from the OBSERVE-PD Study7
Delirium after Deep Brain Stimulation in Parkinson’s Disease7
Parkinsonics: A Randomized, Blinded, Cross-Over Trial of Group Singing for Motor and Nonmotor Symptoms in Idiopathic Parkinson Disease6
Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson’s Disease6
Progression of Nonmotor Symptoms in Parkinson’s Disease by Sex and Motor Laterality6
Delivering Optimal Care to People with Cognitive Impairment in Parkinson’s Disease: A Qualitative Study of Patient, Caregiver, and Professional Perspectives5
Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson’s Disease5
Validation of the Japanese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS)5
Management, Levels of Support, Quality of Life, and Social Inclusion in Parkinson’s Disease: Interventions, Innovation, and Practice Development5
Staging Parkinson’s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life5
Use of a Smartphone to Gather Parkinson’s Disease Neurological Vital Signs during the COVID-19 Pandemic5
Intraoperative Quantitative Measurements for Bradykinesia Evaluation during Deep Brain Stimulation Surgery Using Leap Motion Controller: A Pilot Study5
DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson’s Disease Rat Model5
Cognitive Impairment in Genetic Parkinson’s Disease5
Identification of Potential Core Genes in Parkinson’s Disease Using Bioinformatics Analysis5
Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice4
Abbreviated MDS-UPDRS for Remote Monitoring in PD Identified Using Exhaustive Computational Search4
α-Synuclein E46K Mutation and Involvement of Oxidative Stress in a Drosophila Model of Parkinson’s Disease4
Occupational Therapy for People with Early Parkinson’s Disease: A Retrospective Program Evaluation4
Autonomic Dysfunctions in Parkinson’s Disease: Prevalence, Clinical Characteristics, Potential Diagnostic Markers, and Treatment4
Neuroprotective Effects of Estradiol plus Lithium Chloride via Anti-Apoptosis and Neurogenesis Pathway in In Vitro and In Vivo Parkinson’s Disease Models4
Differences in Home Health Nursing Care for Patients with Parkinson’s Disease by Stage of Progress: Patients in Hoehn and Yahr Stages III, IV, and V4
Quantitative Analysis of Postural Instability in Patients with Parkinson’s Disease4
Onset of Postural Instability in Parkinson’s Disease Depends on Age rather than Disease Duration4
Evaluation of Patients with Parkinson’s Disease in Intensive Care Units: A Cohort Study4
0.024220943450928